Patent details

EP2042191 Title: Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination

Basic Information

Publication number:
EP2042191
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP081649006
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Anaplastic Lymphoma Kinase (ALK) as oncoantigen for lymphoma vaccination
French Title of Invention:
Kinase de lymphome anaplastique (ALK) en tant qu'oncoantigène pour une vaccination contre le lymphome
German Title of Invention:
Anaplastische Lymphom-Kinase (ALK) als Onko-Antigen für die Lymphon-Impfung
SPC Number:

Dates

Filing date:
23/09/2008
Grant date:
02/01/2013
EP Publication Date:
02/01/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/04/2009
EP B1 Publication Date:
02/01/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/09/2013
Expiration date:
23/09/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/09/2008
 
 

Name:
Chiarle Roberto
Address:
Corso Vittorio Veneto, 70, 12038 Savigliano (CN), Italy (IT)

Name:
Forni Guido
Address:
Via dei Mille, 32, 10123 Torino, Italy (IT)

Name:
Inghirami Giorgio
Address:
Frazione Ranello, 71, 14022 Castelnuovo Don Bosco (AT), Italy (IT)

Inventor

1

Name:
Inghirami Giorgio
Address:
Italy (IT)

2

Name:
Forni Guido
Address:
Italy (IT)

3

Name:
Chiarle Roberto
Address:
Italy (IT)

Priority

Priority Number:
960414 P
Priority Date:
28/09/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/00;
Filing date Document type Number of pages